AGP Picks
View all

RX-O2 launches brain health research program with NHSA

Nov. 17, 2026
RX-O2 launches brain health research program with NHSA
By AI, Created 21:51 UTC, Nov 17, 2026, AGP -

RX-O2 Hyperbaric Clinics is partnering with the National Hyperbaric Safety Association on a brain health research initiative focused on hyperbaric oxygen therapy, cognitive function and aging. The planned Phoenix-area program is now accepting inquiries from older adults and families who want to explore screening and possible participation in discounted therapy.

Why it matters: - The initiative could add new data on whether hyperbaric oxygen therapy affects cognitive function in older adults. - The program is designed to clarify who may benefit, how much they may benefit and under what conditions. - The collaboration also puts safety, staff education and structured research methods at the center of the effort.

What happened: - RX-O2 Hyperbaric Clinics announced a partnership with the National Hyperbaric Safety Association to develop a Brain Health Research Program. - The initiative will examine hyperbaric oxygen therapy, cognitive function and aging. - Older adults and families in the greater Phoenix area can contact RX-O2 now to discuss eligibility, screening and possible participation. - The planned cohort includes up to 30 participants, with final eligibility determined through individual screening. - People who inquire may be considered for discounted HBOT through research participation, but an inquiry does not reserve a place or equal enrollment.

The details: - RX-O2 has provided hyperbaric oxygen therapy in the Valley of the Sun for more than 22 years through its Glendale and Scottsdale facilities. - The clinics serve the greater Phoenix area and Maricopa County. - RX-O2 says its experience with patients who have cognitive concerns helped shape the team’s interest in more rigorous evidence. - The program draws inspiration from work tied to the Sagol Center for Hyperbaric Medicine and Research at Shamir Medical Center and Tel Aviv University’s Sagol School of Neuroscience. - A 2020 randomized controlled study of 63 healthy older adults reported improvements in cognitive measures, especially attention and information-processing speed, along with changes in regional brain blood flow. - That study involved healthy aging adults and did not establish that HBOT prevents or treats dementia. - RX-O2 says patient reports of better memory, mental clarity and everyday function have helped motivate the research effort, but those experiences alone cannot prove effectiveness. - The initiative aims to produce findings for peer-reviewed publication. - The research focus includes healthy cognitive aging and cognitive decline associated with Alzheimer’s disease and vascular dementia. - Eligibility for people with specific diagnoses depends on individual clinical screening and program research criteria. - HBOT is not an established treatment for preventing cognitive decline or treating dementia, and the program does not promise improvement. - Planned participation may include review of medical records, standardized cognitive assessments and follow-up. - Laboratory testing or imaging may be required, and some costs may be out of pocket. - Detailed medical records should be shared only through the clinic’s secure process. - Interested people can contact RX-O2 through its website, by phone at 480-685-9022 or by email at info@rx-o2.com. - More information is available on the brain health program page.

Between the lines: - Marvin A. Borsand, D.O., RX-O2’s medical director and a clinical investigator for the initiative, said observing cognitive decline among peers made the question personal and pushed him to review the scientific literature. - Alexander Borsand, M.D., RX-O2’s clinic safety director, will support education and safety oversight. - Alexander Borsand was invited in 2025 to speak about hyperbaric oxygen therapy and cognitive enhancement at an American Academy of Anti-Aging Medicine event. - Melanie Dooley, N.D., a hyperbaric physician and clinical investigator at RX-O2, has developed a research interest in cognitive function and measurable outcomes. - The partnership appears to be as much about formalizing safety and education as it is about testing a clinical hypothesis.

What's next: - RX-O2’s research team will review inquiries and explain next steps for potential participants. - The clinics will screen interested older adults and family members before determining whether they qualify. - The initiative is expected to move forward with structured assessments and follow-up as the cohort is assembled. - RX-O2 says the goal is to generate evidence that can be shared publicly through peer-reviewed publication.

The bottom line: - RX-O2 is turning its long-running hyperbaric practice into a formal brain health study, but the clinics are clear that the work is experimental and does not promise cognitive benefit.

Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.

Sign up for:

World Report Monitor

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

World Report Monitor

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.